체외수정(IVF) 시장 규모, 점유율, 성장 분석 : 제품 유형별, 제품별, 유형별, 기기별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

In Vitro Fertilization Market size was valued at USD 29.05 Billion in 2024 and is poised to grow from USD 31.49 Billion in 2025 to USD 60.04 Billion by 2033, growing at a CAGR of 8.4% during the forecast period (2026-2033).

The global In Vitro Fertilization (IVF) market encompasses assisted reproductive technology procedures that facilitate fertilization outside the human body, gaining widespread acceptance as a solution for couples experiencing infertility. Key procedures-ovarian stimulation, egg retrieval, fertilization, and embryo transfer-are tailored for individuals when natural conception is challenging. As global infertility rates rise due to lifestyle factors and health issues, couples increasingly turn to IVF for family building. Technological advancements, including improved laboratory techniques and genetic testing, enhance success rates, attracting more individuals seeking reliable treatments. Additionally, growing awareness in developing regions provides significant opportunities for market expansion through the establishment of IVF clinics. Continuous evolution in techniques offers hope for couples on their fertility journeys, addressing both emotional and physical challenges.

Top-down and bottom-up approaches were used to estimate and validate the size of the In Vitro Fertilization market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

In Vitro Fertilization Market Segments Analysis

Global In Vitro Fertilization Market is segmented by Product Type, Product, Type, Instrument, End User and region. Based on Product Type, the market is segmented into Fresh Donor, Fresh Non-Donor, Frozen Donor and Frozen Non-Donor. Based on Product, the market is segmented into Equipment, Reagents & Media and Accessories. Based on Type, the market is segmented into Conventional IVF, IVF with ICSI, IVF with Donar Eggs and Others. Based on Instrument, the market is segmented into Culture Media, Disposable Devices and Capital Equipment. Based on End User, the market is segmented into Fertility Clinics, Surgical Centers, Hospitals and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the In Vitro Fertilization Market

The In Vitro Fertilization market is experiencing substantial growth, fueled by ongoing advancements in reproductive technologies that enhance IVF procedures. Innovations such as time-lapse imaging systems facilitate continuous observation of embryo development, which significantly improves selection processes and increases success rates. These technological breakthroughs not only optimize the chances of successful pregnancies but also appeal to a growing number of individuals and couples seeking fertility solutions. As awareness of these advanced methods spreads, more people are opting for IVF treatments, further driving market demand and encouraging continued investment in the development of cutting-edge reproductive technologies.

Restraints in the In Vitro Fertilization Market

The high costs associated with In Vitro Fertilization treatments present a considerable barrier for many individuals and couples seeking fertility solutions. The financial burden stemming from medications, laboratory procedures, and the potential need for multiple treatment cycles can be overwhelming. As a result, IVF may become unattainable for those who lack sufficient financial resources or adequate insurance coverage. This economic constraint not only limits access for a significant segment of the population but may also lead to increased stress and emotional strain for those navigating the challenges of infertility. Addressing these financial obstacles is crucial for expanding access to IVF.

Market Trends of the In Vitro Fertilization Market

The In Vitro Fertilization market is experiencing a notable shift towards the integration of genetic testing techniques, particularly preimplantation genetic testing (PGT). This trend reflects an increasing demand among prospective parents for enhanced reproductive options aimed at improving the likelihood of successful pregnancies and minimizing the risk of genetic disorders in children. As couples seek to optimize their IVF outcomes, the adoption of PGT and similar technologies is expected to expand, driving innovation and creating new market opportunities. This growing emphasis on genetic screening aligns with broader healthcare initiatives focused on personalized medicine and enhanced reproductive health solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis

Global In Vitro Fertilization Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Fresh Donor
• Fresh Non-Donor
• Frozen Donor
• Frozen Non-Donor

Global In Vitro Fertilization Market Size by Product & CAGR (2026-2033)

• Market Overview
• Equipment
  • Sperm Analyzer Systems
  • Imaging Systems
  • Ovum Aspiration Pumps
  • Micromanipulator Systems
  • Incubators
  • Gas Analyzers
  • Laser Systems
  • Cryosystems
  • Sperm Separation Devices
  • IVF Cabinets
  • Anti-vibration Tables
  • Witness Systems
  • Other Equipments
• Reagents & Media
  • Cryopreservation Media
  • Embryo Culture Media
  • Ovum Processing Media
  • Sperm Processing Media
• Accessories

Global In Vitro Fertilization Market Size by Type & CAGR (2026-2033)

• Market Overview
• Conventional IVF
• IVF with ICSI
• IVF with Donar Eggs
• Others

Global In Vitro Fertilization Market Size by Instrument & CAGR (2026-2033)

• Market Overview
• Culture Media
• Disposable Devices
• Capital Equipment

Global In Vitro Fertilization Market Size by End User & CAGR (2026-2033)

• Market Overview
• Fertility Clinics
• Surgical Centers
• Hospitals
• Research Institutes

Global In Vitro Fertilization Market Size & CAGR (2026-2033)

• North America (Product Type, Product, Type, Instrument, End User)
  • US
  • Canada
• Europe (Product Type, Product, Type, Instrument, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Product, Type, Instrument, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Product, Type, Instrument, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Product, Type, Instrument, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Ferring Pharmaceuticals (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vitrolife AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CooperSurgical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ovascience, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Irvine Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genea Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Origio A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Esco Medical ApS (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nidacon International AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston IVF (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virtus Health (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bloom Fertility Centre (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rainbow IVF (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IVI RMA Global (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CHA Healthcare (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reproductive Medicine Associates of New Jersey (RMANJ) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TSLC Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations